About

I am an award-winning writer, editor, photographer and designer with more than 30 years of experience in the media. After studying at the University of Leeds, then London and Anglia HEC, I moved to Canada in the 1980s and started out on the radio while also writing for various music and sports publications, and doing freelance photography. I then edited some magazines before working at a science organization, doing communications and editing publications in a programming language called LaTeX that was challenging but exciting.

Following that, I edited a newspaper, spent some time in the US, and then moved back to the UK where I edited a food B2B publication.
I’ve written, and taken photographs for, hundreds of publications around the world, as well as for books, album covers, DVDs, and shot coverage for documentaries. I’ve edited books, written nine of my own, and done redesigns for several publications. And now I’m writing about biotech, as well as creating videos and a weekly podcast.

I’ve done other things, like running an aquarium, teaching photography and drumming (not at the same time), and running football (soccer) refereeing courses.

In what spare time I have, I love spending time with my wife, son and dog, challenging hikes up the Scottish hills (and down again), playing and writing music, watching baseball and soccer, and collecting memorabilia and autographs.

Articles by Jim Cornall

Rocket Pharmaceuticals receives FDA RMAT designation for Danon disease gene therapy treatment

Heartseed and Novo Nordisk dose first patient in heart failure cell therapy study

Europe approves childhood epilepsy treatment

Beyond Biotech podcast 33: Astellas Pharma, Innovation Agency Lithuania, 4basebio

Talking about Alzheimer’s disease: current drugs, clinical trials, and the pipeline

New method to design new peptide therapeutics

ADVERTISEMENT

Cell and Gene Therapy Catapult boost for life science campus

Icosagen receives €18M loan for R&D and new facility

TILT Biotherapeutics closes €22M financing for oncology immunotherapy trials

First toxic shock syndrome vaccine phase 2 study completed

Cleveland Clinic breast cancer vaccine study moves forward

Antibody candidate for treating serious liver disease

ADVERTISEMENT